Outcomes of a mandatory non-medical switch of infliximab to a biosimilar for inflammatory bowel disease in British Columbia, Canada [0.03%]
加拿大不列颠哥伦比亚省炎症性肠病患者强制切换英夫利昔单抗生物类似药的结局研究
Thomas Tam Hoang,Jacqueline Reid,Cherry Galorport et al.
Thomas Tam Hoang et al.
Background: Despite infliximab biosimilars becoming widely used in inflammatory bowel disease (IBD) patients, real-world non-medical switching is sparse. A biosimilar non-medical switch was launched in British Columbia in...
Removal of a migrated biliary stent buried in a common bile duct stone using electrohydraulic lithotripsy [0.03%]
用体外震波取出嵌入胆总管结石内的移位胆道支架管
Tsuyoshi Suda,Masahiro Yanagi,Naoki Oishi et al.
Tsuyoshi Suda et al.
Post-polypectomy surveillance: follow-up recommendations from the Alberta Colorectal Cancer Screening Program [0.03%]
结肠息肉切除术后的内镜随访筛查:来自阿尔伯塔省结直肠癌筛查项目的建议
Daniel C Sadowski,Michael R Kolber,Anthony Gomes et al.
Daniel C Sadowski et al.
In 2013, the Alberta Colorectal Cancer Screening Program (ACRCSP) initially published recommendations for post-colonoscopy follow-up and polypectomy. Over time, emerging evidence and evolving surveillance guidelines from various expert grou...
The relationship among vedolizumab drug concentrations, biomarkers of inflammation, and clinical outcomes in a Canadian real-world study [0.03%]
加拿大真实世界研究中 Vedolizumab 药物浓度、炎症生物标志物和临床结局之间的关系
Cynthia H Seow,John K Marshall,Erin Stewart et al.
Cynthia H Seow et al.
Background and aims: Therapeutic drug monitoring is used to optimize anti-tumour necrosis factor biologic effectiveness in inflammatory bowel disease, but its role with other biological classes is unclear. This study expl...
Practical guidance for managing patients with moderate-to-severe ulcerative colitis using small molecule therapies [0.03%]
使用小分子药物治疗中至重度溃疡性结肠炎患者的实用指导原则
Vipul Jairath,Waqqas Afif,Brian Bressler et al.
Vipul Jairath et al.
Ulcerative colitis (UC) is a severe and debilitating illness that affects the quality of life and physical health of many Canadians. Given the dynamic and progressive nature of the disease, advanced therapies are required to support its lon...
Success of Helicobacter pylori Guideline-based Treatment of Newly Diagnosed and Previously Treated Patients During 2007-2021 in Edmonton, Alberta [0.03%]
加拿大艾伯塔省埃德蒙顿市2007年至2021年新诊断和既往治疗的幽门螺杆菌患者的基于指南治疗的成功率
Thomas Krahn,Jonas Buttenschoen,Pernilla DSouza et al.
Thomas Krahn et al.
Background: Updated 2016 Helicobacter pylori consensus guidelines recommend treatment for 14 days with concomitant therapy (proton-pump inhibitor (PPI)-amoxicillin-metronidazole-clarithromycin (PAMC) or bismuth-based quad...
Storytelling of Indigenous patient and family advocates engaged in patient-oriented research initiatives in the field of inflammatory bowel disease [0.03%]
炎症性肠病领域患者导向研究计划中原住民患者及家属倡导者的故事讲述
Rhonda Sanderson,Linda Porter,Robert Porter et al.
Rhonda Sanderson et al.
Background and aim: The history of colonization and its ongoing impact poses significant health disparities among Indigenous communities. We aimed to centre the voices and stories of Indigenous patients and family advocat...
Gastroscopy for dyspeptic symptoms in patients <65 years has a low yield of clinically important findings: a retrospective study [0.03%]
胃镜检查患者的消化不良症状
Brooke Maracle,Katelynn Crick,Kerri Novak et al.
Brooke Maracle et al.
Background: Dyspepsia is a common, generally low-risk gastrointestinal condition. The American College of Gastroenterology and Canadian Association of Gastroenterology recommend avoiding gastroscopy in healthy patients
Kareem Khalaf,Carmen Ching Hui Yee,Tao Wang et al.
Kareem Khalaf et al.
Perceived value of computed tomography imaging for patients with inflammatory bowel disease in the emergency department: a Canadian survey [0.03%]
加拿大一项关于炎症性肠病急诊患者CT检查价值的认知调查
Caleb A N Roda,Catherine Dube,Blair D Macdonald et al.
Caleb A N Roda et al.
Background: There are high rates of computed tomography (CT) utilization in the emergency department (ED) for patients with inflammatory bowel disease (IBD), despite guidelines recommending judicious use. We performed a n...